Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.75
Delayed Data
As of 11:27am ET
 -0.0101 / -0.37%
Today’s Change
2.51
Today|||52-Week Range
7.70
-50.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-8.8M-10.6M-9.0M-12.5M
 
 
 
 
 
Depreciation87.0K77.0K53.0K70.0K
 
 
 
 
 
Total Other Cash Flow1.8M2.2M747.0K5.0M
 
 
 
 
 
Funds From Operations-6.9M-8.4M-8.2M-9.0M
 
 
 
 
 
Funds From/For Other Operating Expenses881.0K-1.1M-434.0K530.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-7.8M-7.3M-7.8M-9.5M
 
 
 
 
 
 
InvestingIncrease In Investments-5.0M-8.0M-2.0M0.00
 
 
 
 
Decrease In Investments8.0M2.5M7.5M0.00
 
 
 
 
Capital Expenditures-95.0K-57.0K-4.0K-203.0K
 
 
 
 
 
Fixed Asset Disposal12.0K0.00--100.0K
 
 
 
Other Investing - Uses0.000.00-150.0K0.00
 
 
Net Cash Flow Investing2.9M-5.6M5.3M-103.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.9M9.5M0.00292.0K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends------0.00--
Cash Dividends Paid - Total------0.00--
Other Sources - Financing0.000.0010.2M0.00
 
 
Other Uses - Financing0.000.00--0.00--
Net Cash Flow - Financing1.9M9.5M10.2M292.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-2.9M-3.4M7.8M-9.3M